BioSpace News Archive

Press Releases

EyePoint Pharmaceuticals Announces Positive Interim 16-Week Data for Ongoing Phase 2 VERONA Clinical Trial of DURAVYU™ for Diabetic Macular Edema

October 28, 2024
·
12 min read
Press Releases

I-Mab to Participate at the Truist Securities BioPharma Symposium

October 28, 2024
·
1 min read
Press Releases

Precision BioSciences to Host Virtual Investor Event Highlighting PBGENE-HBV Preclinical Safety Data and Phase 1 Clinical Trial Plans on November 15, 2024

October 28, 2024
·
8 min read
Press Releases

Lilly’s mirikizumab is first and only IL23p19 antagonist to report long-term, multi-year, sustained efficacy and safety data for both ulcerative colitis and Crohn’s disease

October 28, 2024
·
14 min read
Press Releases

Odyssey Therapeutics and Terray Therapeutics Enter Strategic Collaboration to Jointly Discover and Develop First-in-Class Transcription Factor Therapies

October 28, 2024
·
4 min read
Press Releases

Castle Biosciences to Participate in Upcoming Investor Conferences

October 28, 2024
·
1 min read
Press Releases

Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024

October 28, 2024
·
17 min read
Press Releases

NLS Pharmaceutics Ltd. Regains Full Compliance with Nasdaq Listing Requirements

October 28, 2024
·
1 min read
Press Releases

Zimmer Biomet to Debut New Z1™ Femoral Hip System and Clinical Data on G7® Acetabular System at 2024 AAHKS Annual Meeting

October 28, 2024
·
6 min read
Press Releases

Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting

October 28, 2024
·
5 min read